ENGENEIC
Updated 111 days ago
275 Madison Avenue, 27th Floor, New York, New York 10016
EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer.
Also known as: EnGeneIC Inc, EnGeneIC Ltd, EnGeneIC Pty Ltd.